The small molecule raptinal can simultaneously induce apoptosis and inhibit PANX1 activity

Jascinta P. Santavanond,Yu-Hsin Chiu,Rochelle Tixeira,Zonghan Liu,Jeremy K. Y. Yap,Kaiwen W. Chen,Chen-Lu Li,Yi-Ru Lu,Joan Roncero-Carol,Esteban Hoijman,Stephanie F. Rutter,Bo Shi,Gemma F. Ryan,Amy L. Hodge,Sarah Caruso,Amy A. Baxter,Dilara C. Ozkocak,Chad Johnson,Zoe I. Day,Alyce J. Mayfosh,Mark D. Hulett,Thanh K. Phan,Georgia K. Atkin-Smith,Ivan K. H. Poon

DOI: https://doi.org/10.1038/s41419-024-06513-z

2024-02-09

Cell Death and Disease

Abstract:Discovery of new small molecules that can activate distinct programmed cell death pathway is of significant interest as a research tool and for the development of novel therapeutics for pathological conditions such as cancer and infectious diseases. The small molecule raptinal was discovered as a pro-apoptotic compound that can rapidly trigger apoptosis by promoting the release of cytochrome c from the mitochondria and subsequently activating the intrinsic apoptotic pathway. As raptinal is very effective at inducing apoptosis in a variety of different cell types in vitro and in vivo, it has been used in many studies investigating cell death as well as the clearance of dying cells. While examining raptinal as an apoptosis inducer, we unexpectedly identified that in addition to its pro-apoptotic activities, raptinal can also inhibit the activity of caspase-activated Pannexin 1 (PANX1), a ubiquitously expressed transmembrane channel that regulates many cell death-associated processes. By implementing numerous biochemical, cell biological and electrophysiological approaches, we discovered that raptinal can simultaneously induce apoptosis and inhibit PANX1 activity. Surprisingly, raptinal was found to inhibit cleavage-activated PANX1 via a mechanism distinct to other well-described PANX1 inhibitors such as carbenoxolone and trovafloxacin. Furthermore, raptinal also interfered with PANX1-regulated apoptotic processes including the release of the 'find-me' signal ATP, the formation of apoptotic cell-derived extracellular vesicles, as well as NLRP3 inflammasome activation. Taken together, these data identify raptinal as the first compound that can simultaneously induce apoptosis and inhibit PANX1 channels. This has broad implications for the use of raptinal in cell death studies as well as in the development new PANX1 inhibitors.

cell biology

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to discover a new small - molecule compound - raptinal, which can not only induce apoptosis but also inhibit the activity of Pannexin 1 (PANX1) channels simultaneously. Specifically:

1. **Inducing apoptosis**: Raptinal was found to be an effective pro - apoptotic compound, which can rapidly trigger apoptosis in many different types of cells. This effect is achieved by promoting the release of cytochrome c from mitochondria to activate the intrinsic apoptotic pathway.

2. **Inhibiting PANX1 activity**: During the study of raptinal as an apoptosis inducer, researchers unexpectedly found that raptinal can also inhibit the activity of PANX1 channels activated by caspase. PANX1 is a ubiquitously expressed transmembrane channel and is involved in regulating many processes related to cell death.

3. **Uniqueness of the mechanism**: The inhibitory effect of raptinal on PANX1 is different from other known PANX1 inhibitors (such as carbenoxolone and trovafloxacin). This means that raptinal may exert its inhibitory effect through a unique mechanism.

4. **Affecting the apoptosis process**: Raptinal can not only induce apoptosis but also interfere with the PANX1 - regulated apoptosis process, including the release of ATP (as a "find - me" signal), the formation of extracellular vesicles derived from apoptotic cells, and the activation of NLRP3 inflammasomes.

These findings are of great significance for cell death research and the development of new PANX1 inhibitors. Raptinal may be the first compound that can simultaneously induce apoptosis and inhibit PANX1 channels, which provides a new tool for studying cell death mechanisms and developing new therapeutic drugs.